Associate Director, Health Economics & Outcomes Research
GSK
Disclosure(s): GSK: employee, Stocks/Bonds (Private Company)
Emily Horn (MSc) is an Associate Director on GSK's US Medical Affairs Vaccines team supporting Health Economics and Outcomes Research (HEOR) evidence generation activities for multiple vaccines in GSK’s portfolio. Her past role was at Pfizer in the Patient & Health Impact Vaccines team, where she contributed to the development and operationalization of the global HEOR strategy for inline and pipeline pneumococcal vaccines. Emily previously worked as an Economist at RTI International in their Center for Health Policy Science and Tobacco Research, where she conducted quantitative research to evaluate US tobacco control policies and media campaigns for the FDA and state governments. Emily earned her Master’s degree in International Health Policy from the London School of Economics and her Bachelor’s degree in Global Health and Public Policy from Duke University.